Learn to implement current and emerging lipid guidelines into a high-functioning cardiometabolic clinic using modern risk assessment tools, biomarkers, and individualized treatment strategies. Gain practical insights to optimize care for high-risk patients, including those with chronic kidney disease and cardiometabolic conditions.
Accreditation Statement
In accordance with ACCME policy, prior to participating in this activity, you must review the information on this page.
Joint Accreditation Statement:
In support of improving patient care, the American College of Cardiology Foundation (ACCF) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
MOC:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program.
Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Credit Designation Statement:
Physicians:
The ACCF designates this internet enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses:
The ACCF designates this educational activity for a maximum of 1.5 continuing nursing education contact hours.
Physician Associates:
AAPA Credit Designation Statement – Enduring Materials
The American College of Cardiology Foundation has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid until 04/30/2027 PAs should only claim credit commensurate with the extent of their participation.
Interprofessional Continuing Education (ICPE) Credit:
This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credits for learning and change.
Target Audience:
This course is intended for physicians, nurses, physician associates and the cardiovascular care team.
Important Dates:
Date of Release: April 30, 2026
Term of Approval/Date of Expiration: April 30, 2027
Learner Objectives:
Upon completion, participants should be able to:
- Discuss key concepts in risk related to cardio-kidney-metabolic syndrome (CKM) in the context of caring for patients with elevated lipid levels and other comorbid conditions.
- Assess how advanced lipid-management care plans may affect overall management for patients with dyslipidemia.
- Examine the core components of establishing a lipid and cardiometabolic clinic.
- Consider the roles and responsibilities of the cardiology interprofessional care team when managing patients with dyslipidemia in various settings.
Grant Acknowledgement:
Educational grant support for this activity provided by Amgen, Boehringer Ingelheim, Esperion, Merck Sharp & Dohme LLC, and Novartis.
Planning Committee
Eugenia Gianos, MD, FACC
Pamela B. Morris, MD, FACC
Anum Saeed, MD
Vijay Nambi, MBBS, FACC
Chiadi E. Ndumele, MD, PhD
John D. Bucheit, PharmD, AACC
Michael J. Blaha, MD, MPH
Salim S. Virani, MD, PhD, FACC
Chris Owen, ACNP-BC, AAC
Faculty
Eugenia Gianos, MD, FACC
Pamela B. Morris, MD, FACC
Anum Saeed, MD
Vijay Nambi, MBBS, FACC
Chiadi E. Ndumele, MD, PhD
John D. Bucheit, PharmD, AACC
Michael J. Blaha, MD, MPH
Salim S. Virani, MD, PhD, FACC